Transcranial Direct Current Stimulation and Extinction in Obsessive Compulsive Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorYale University

About this trial

Obsessive-compulsive disorder (OCD) is associated with substantial impairments in quality of life and is among the most disabling psychiatric disorders. Exposure therapy is among the first-line of treatments for obsessive-compulsive disorder (OCD) . Extinction learning is thought to be a core mechanism of therapeutic exposure. Fear and safety signal learning are traditionally associated with activity and connectivity within the canonical corticolimbic "fear circuit", which includes the amygdala, medial prefrontal cortex (mPFC), and hippocampus. Transcranial direct current stimulation (tDCS) is a neuromodulation technology that can augment brain plasticity, learning, and memory. The proposed study will test if obsessive-compulsive disorder (OCD) is associated with inhibitory safety learning deficits and if transcranial direct current stimulation (tDCS) normalizes functional connectivity and safety signal processing to recover extinction deficits in obsessive-compulsive disorder (OCD).

Eligibility criteria

Qualifiers

18 years of age or older

speak English fluently, and

able to provide written and verbal informed consent.

meet criteria for OCD as determined by structured clinical interview

Disqualifiers

active severe substance use disorder(s)

acute suicidality

history of bipolar or psychotic disorder(s)

significant developmental disabilities

Trial design

Treatments tested in this trial

  • Active transcranial direct current stimulation
  • Sham transcranial direct current stimulation

Treatment groups

180 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Yale University

Lead sponsor

National Institute of Mental Health (NIMH)

Collaborator